Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 13, Number 9—September 2007


HIV, Hepatitis C, and Hepatitis B Infections and Associated Risk Behavior in Injection Drug Users, Kabul, Afghanistan

Catherine S. Todd*, Abdullah M.S. Abed†, Steffanie A. Strathdee*, Paul T. Scott‡Comments to Author , Boulos A. Botros§, Naqibullah Safi†, and Kenneth C. Earhart§
Author affiliations: *University of California, San Diego, La Jolla, California, USA; †Ministry of Public Health, Kabul, Afghanistan; ‡Walter Reed Army Institute of Research, Rockville, Maryland, USA; §United States Naval Medical Research Unit 3, Cairo, Egypt;

Main Article


Factors independently associated with HCV infection (n = 170) by multivariable analysis in 463 male injection drug users, Kabul, Afghanistan*

Factor Value
HCV prevalence 107 (36.8)
Demographic factors
Married 0.60 (0.40–0.92)
Higher educational level 0.51 (0.29–0.88)
Drug practices
Ever shared needle or syringe 2.60 (1.71–3.96)
Duration injection drug use >3 y 3.28 (2.17–4.96)
Medical encounters
Injections by a nonmedical provider   2.71 (1.26–5.82)

*HCV, hepatitis C virus. Values are no. (%) or adjusted odds ratio (95% confidence interval). Analysis was adjusted for marital status, educational level, duration of injecting, sharing needles or syringes, and injections by a nonmedical provider.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO